Ali Pourmoghaddas

Ali Pourmoghaddas

Auto-generated profile, based on publicly available information

Ali Pourmoghaddas

Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Nutrition
Verified
Journal Article
Open access
NSNizal Sarrafzadegan
Nizal Sarrafzadegan
HKHossein Khosravi-Boroujeni
Hossein Khosravi-Boroujeni
MLMasoud Lotfizadeh
Masoud Lotfizadeh
APAli Pourmogaddas
Ali Pourmogaddas
ASAmin Salehi-Abargouei
Amin Salehi-Abargouei
To systematically review the published evidence regarding the association between Mg intake and serum concentrations with MetS and, if possible, to summarize the results using a meta-analysis. PubMed, ISI Web of Science, Scopus, and Google Scholar were searched to identify related articles. Fully adjusted odds ratios (ORs) of MetS in participants with the highest intake of Mg compared with those who had the least consumption, and the mean difference in serum Mg levels between patients with MetS and their controls were extracted for the meta-analysis. In total, 9 articles with 31 876 participants were included in the meta-analysis regarding the association between dietary Mg intake and MetS, and 8 studies that assessed the mean level of serum Mg in 3487 individuals with and without MetS were eligible. Our analysis found that higher consumption of Mg is associated with lower risk of MetS (OR = 0.73; 95% confidence interval: 0.62, 0.86; P < 0.001); we also could find a significant but heterogeneous association between serum Mg and MetS (mean difference: -0.19; 95% confidence interval: -0.36, 0.03; P = 0.023). The present systematic review and meta-analysis found an inverse association between Mg intake and MetS. However, the inverse association for serum Mg levels was highly heterogeneous and sensitive. The link between Mg status and MetS should be confirmed by prospective cohort studies controlling the association for other nutrients related to MetS risk.

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
AMAhmad Mirdamadi
Ahmad Mirdamadi
MGMohammad Garakyaraghi
Mohammad Garakyaraghi
APAli Pourmoghaddas
Ali Pourmoghaddas
ABAlireza Bahmani
Alireza Bahmani
HMHamideh Mahmoudi
Hamideh Mahmoudi
MGMojgan Gharipour
Mojgan Gharipour
Background.According to the present evidences suggesting association between low testosterone level and prediction of reduced exercise capacity as well as poor clinical outcome in patients with heart failure, we sought to determine if testosterone therapy improves clinical and cardiovascular conditions as well as quality of life status in patients with stable chronic heart failure.Methods.A total of 50 male patients who suffered from congestive heart failure were recruited in a double-blind, placebo-controlled trial and randomized to receive an intramuscular (gluteal) long-acting androgen injection (1 mL of testosterone enanthate 250 mg/mL) once every four weeks for 12 weeks or receive intramuscular injections of saline (1 mL of 0.9% wt/vol NaCl) with the same protocol.Results.The changes in body weight, hemodynamic parameters, and left ventricular dimensional echocardiographic indices were all comparable between the two groups. Regarding changes in diastolic functional state and using Tei index, this parameter was significantly improved. Unlike the group received placebo, those who received testosterone had a significant increasing trend in 6-walk mean distance (6MWD) parameter within the study period (P=0.019). The discrepancy in the trends of changes in 6MWD between study groups remained significant after adjusting baseline variables (mean square = 243.262,Findex = 4.402, andP=0.045).Conclusion.Our study strengthens insights into the beneficial role of testosterone in improvement of functional capacity and quality of life in heart failure patients.

1 May 2009
Verified
Journal Article
Closed access
STShahram Taheri
Shahram Taheri
MMMojgan Mortazavi
Mojgan Mortazavi
SSSiamak Shahidi
Siamak Shahidi
APAli Pourmoghadas
Ali Pourmoghadas
MGMohammad Garakyaraghi
Mohammad Garakyaraghi
MGMaryam Ghassami
Maryam Ghassami

2 September 2016 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
FDFaramarz Darabi
Faramarz Darabi
MAMahmoud Aghaei
Mahmoud Aghaei
AMAhmad Movahedian
Ahmad Movahedian
APAli Pourmoghadas
Ali Pourmoghadas
NSNizal Sarrafzadegan
Nizal Sarrafzadegan

1 July 2003 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
APAli Pourmoghaddas
Ali Pourmoghaddas
AHAli Hekmatnia
Ali Hekmatnia

29 December 2015 in BMC Public Health
Verified
Journal Article
Open access
PDF file
HKHossein Khosravi-Boroujeni
Hossein Khosravi-Boroujeni
FAFaruk Ahmed
Faruk Ahmed
MSMasoumeh Sadeghi
Masoumeh Sadeghi
HRHamidreza Roohafza
Hamidreza Roohafza
MTMohammad Talaei
Mohammad Talaei
NSNizal Sarrafzadegan
Nizal Sarrafzadegan
Metabolic Syndrome (MetS) is a complex disorder which increases the risk of chronic diseases, including cardiovascular diseases and diabetes mellitus. As a result of modern lifestyles, the prevalence of MetS has been rising globally. This study aims to investigate whether overall prevalence of MetS varies when using different definitions of MetS and to identify the best and most predictive definition of the MetS for cardiovascular disease (CVD) events over 10 years in a cohort of an Iranian population. Adults aged ≥ 35 years from urban and rural regions in central Iran were selected at baseline and followed up for more than 10 years. Data on socio-demographic characteristics, anthropometry, blood pressure and smoking status were collected at baseline. In addition, various biochemical indices were assessed. MetS was defined based on five available definitions, and cardiovascular events during 10 years follow up were confirmed by an expert group. The hazard ratios were calculated by the Cox proportional hazards model. The highest prevalence of MetS was observed by using AHA-NHBI definition (36.9 %), followed by JIS definition (31.2 %). On the other hand, EGIR (8.8 %) provided the lowest prevalence. The risk of developing CVD, irrespective of definitions, was approximately two fold higher in the presence of MetS. After controlling for possible confounders, AHA-NHBI definition was found to be the best predictor of CVD. This study demonstrated a great variability in the prevalence of MetS among Iranian adults when using different definitions of MetS. CVD risk was significantly higher in MetS participants, as well as in participants with any risk factors of MetS; however, the AHA-NHBI definition was found to be the best predictor of CVD. Thus protective measures, including lifestyle modifications, plus control of individual risk factors is necessary to prevent cardiovascular events.